Loading stock data...

Medico Intercontinental Limite

BSE: MIL

BSE
35.89 -0.30 (-0.83%)

Prev Close

36.19

Open Price

36.54

Volume

6,457

Today Low / High

34.25 / 36.54

52 WK Low / High

32.71 / 56

Range

34 - 38

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 35.89, reflecting a change of -0.3 (-0.82896%). The expected target range on the BSE is 34 - 38. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

08 Oct 36.54 -1.78%
07 Oct 37.00 -2.19%
06 Oct 38.00 -3.24%
03 Oct 36.06 4.74%
01 Oct 39.44 -6.97%
30 Sep 38.70 -2.43%
29 Sep 38.89 -5.25%
26 Sep 39.50 -9.27%
25 Sep 38.00 -4.76%
24 Sep 39.00 -6.21%
23 Sep 39.00 -3.67%
22 Sep 39.00 -5.13%
19 Sep 39.00 -2.46%
18 Sep 39.40 -4.57%
17 Sep 39.50 -5.42%
16 Sep 37.49 -0.43%
15 Sep 37.88 -2.03%
12 Sep 38.00 -2.66%
11 Sep 39.00 -4.54%
10 Sep 36.50 2.60%

Medico Intercontinental Limite Graph

Medico Intercontinental Limite Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Medico Intercontinental Limite T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 35.89, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 35.89 36.25 32.62 - 39.87
36.61 29.29 - 43.93
36.97 25.88 - 48.06
Bearish Scenario 35.89 35.53 31.98 - 39.08
35.17 28.14 - 42.21
34.81 24.37 - 45.26

Overview of Medico Intercontinental Limite

ISIN

INE858Q01019

Industry

Financial - Conglomerates

Vol.Avg

3,222

Market Cap

358,900,000

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

-65.31

DCF

105

Financial Ratios Every Investor Needs

Stock Dividend of MIL

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2023-06-23 June 23, 23 0.1 0.1 2023-06-23 2023-07-30

Stock Rating Details for MIL

Metric Value Recommendation
Overall Rating B Neutral
DCF Score 5 Strong Buy
ROE Score 3 Neutral
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 3 Neutral
Price-to-Book (PB) Score 4 Buy

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 96.02 Cr 74.60 Cr 21.41 Cr 0.2230 0.00 Cr 5.15 Cr 7.61 Cr 5.06 Cr 5.04 8.78 Cr 0.0527
2024-03-31 71.51 Cr 54.88 Cr 16.63 Cr 0.2326 0.00 Cr 0.70 Cr 10.21 Cr 3.95 Cr 3.95 6.22 Cr 0.0552
2023-03-31 76.23 Cr 62.31 Cr 14.21 Cr 0.1864 0.00 Cr 0.79 Cr 9.84 Cr 3.61 Cr 5.61 5.77 Cr 0.0473
2022-03-31 74.38 Cr 60.85 Cr 13.53 Cr 0.1819 0.00 Cr 0.50 Cr 9.08 Cr 3.10 Cr 9.54 5.33 Cr 0.0417
2021-03-31 69.77 Cr 57.63 Cr 12.14 Cr 0.1741 0.00 Cr 0.53 Cr 4.83 Cr 2.58 Cr 7.93 4.96 Cr 0.0369

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 2.69 Cr 75.76 Cr 27.12 Cr 48.6495 Cr 16.92 Cr 14.23 Cr 9.24 Cr 3.62 Cr 0.00 Cr 0.00 Cr 0.02 Cr 12.7636 Cr
2024-03-31 3.37 Cr 56.04 Cr 11.01 Cr 45.0321 Cr 4.85 Cr 1.49 Cr 10.47 Cr 2.39 Cr 0.00 Cr 0.00 Cr 0.02 Cr 8.9907 Cr
2023-03-31 6.79 Cr 58.88 Cr 17.69 Cr 41.1850 Cr 4.72 Cr -2.07 Cr 8.88 Cr 1.44 Cr 0.00 Cr 0.00 Cr 0.02 Cr 15.3641 Cr
2022-03-31 1.87 Cr 31.92 Cr 19.29 Cr 12.6351 Cr 8.74 Cr 6.87 Cr 7.88 Cr 1.22 Cr 0.00 Cr 0.00 Cr 0.01 Cr 13.0307 Cr
2021-03-31 0.51 Cr 30.65 Cr 21.11 Cr 9.5354 Cr 9.31 Cr 8.79 Cr 9.11 Cr 1.21 Cr 0.00 Cr 0.00 Cr 0.16 Cr 14.5435 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -7.1145 Cr -2.1868 Cr 8.6260 Cr -9.1139 Cr -0.6753 Cr 2.6899 Cr -1.9994 Cr 6.9732 Cr 12.0695 Cr 0.0000 Cr 1.1955 Cr
2024-03-31 5.5766 Cr -8.5388 Cr -0.4579 Cr 4.3418 Cr -3.4202 Cr 3.3652 Cr -1.2348 Cr 3.9471 Cr -0.3465 Cr -0.1000 Cr -1.5623 Cr
2023-03-31 -10.1032 Cr -5.3847 Cr 20.4082 Cr -10.5250 Cr 4.9203 Cr 6.7854 Cr -0.4218 Cr 3.6082 Cr -3.9150 Cr 0.0000 Cr -0.9956 Cr
2022-03-31 3.8494 Cr -1.2980 Cr -1.2010 Cr 3.6381 Cr 1.3503 Cr 1.8651 Cr -0.2113 Cr 3.0997 Cr -0.2988 Cr 0.0000 Cr 1.2293 Cr
2021-03-31 5.8182 Cr -0.9403 Cr -5.1419 Cr 5.6093 Cr -0.2640 Cr 0.5148 Cr -0.2089 Cr 2.5762 Cr -6.5328 Cr 0.0000 Cr -0.4338 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 21.35 Cr 16.08 Cr 5.27 Cr 0.2469 3.32 Cr -0.68 Cr -0.68 0.93 Cr -0.0318
2025-03-31 21.39 Cr 16.91 Cr 4.48 Cr 0.2095 1.72 Cr 1.17 Cr 1.17 2.08 Cr 0.0546
2024-12-31 19.15 Cr 14.58 Cr 4.57 Cr 0.2387 1.78 Cr 1.17 Cr 1.17 2.12 Cr 0.0613
2024-09-30 37.24 Cr 28.86 Cr 8.38 Cr 0.2249 2.58 Cr 1.63 Cr 1.63 2.83 Cr 0.0438
2024-06-30 18.36 Cr 14.25 Cr 4.11 Cr 0.2240 1.54 Cr 1.08 Cr 1.08 1.74 Cr 0.0590

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-06-30 0.00 Cr 0.00 Cr 2.69 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -48.65 Cr
2025-03-31 2.69 Cr 0.00 Cr 2.69 Cr 33.86 Cr 9.24 Cr 56.58 Cr 3.62 Cr 75.76 Cr 27.12 Cr
2024-12-31 0.00 Cr 0.00 Cr 6.24 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -47.76 Cr
2024-09-30 6.24 Cr 0.00 Cr 6.24 Cr 32.24 Cr 7.35 Cr 47.98 Cr 4.05 Cr 67.19 Cr 19.44 Cr
2024-06-30 3.37 Cr 0.00 Cr 3.37 Cr 0.00 Cr 0.00 Cr 3.37 Cr 0.00 Cr 0.00 Cr -45.03 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 -0.68 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 1.17 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 1.17 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 1.63 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 1.08 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Financial - Conglomerates

Company Name Symbol Price Market Cap Volume
Bajaj Finserv Ltd. BAJAJFINSV ₹2,013.60 ₹3,214,202,610,847.00 ₹369,525.00
Aditya Birla Capital Limited ABCAPITAL ₹295.25 ₹771,343,577,500.00 ₹5,341,724.00
IndiGrid Infrastructure Trust INDIGRID-IV ₹168.49 ₹140,614,677,420.00 ₹986,025.00

Key Executives

MD & Director
Mr. Samir Dilipkumar Shah

Gender: male

Year Born:

Chief Executive Officer
Mr. Dilipkumar Bhogilal Shah

Gender: male

Year Born:

Chief Financial Officer
Mr. Jay Sharadkumar Shah

Gender: male

Year Born:

FAQs about Medico Intercontinental Limite

Who is the CEO of the company?

The CEO is Dilipkumar Bhogilal Shah.

What is the current market price of the stock?

The current price is ₹35.89.

What is the 52-week price range?

The range is ₹32.71-56.

What is the market capitalization of the company?

The market capitalization is ₹35.89 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 10.86.

Which sector does the company belong to?

The company operates in the Financial Services sector.

What does the company do?

Overview of Medico Intercontinental Limite (ISIN: INE858Q01019) is a leading Financial - Conglomerates in India. With a market capitalization of ₹35.89 crores and an average daily volume of 3,222 shares, it operates in the Financial - Conglomerates. The company last declared a dividend of ₹0.